Ovintiv price target raised to $60 from $58 at Scotiabank

Scotiabank raised the firm’s price target on Ovintiv to $60 from $58 and keeps an Outperform rating on the shares. The firm believes years of underinvestment and continued capital discipline have set the foundation for a structurally favorable outlook of Canadian commodity prices, the analyst tells investors.